CDSCO Panel Accepts BE Report, Tells Intas Pharma to Conduct Phase III Trial for Semaglutide Dr. Divya Colin28 May 2025 3:00 PM ISTNew Delhi: In response to a proposal submitted by Intas Pharmaceuticals, the Subject Expert Committee (SEC) under the Central Drugs Standard Control...
PCI Orders Pharmacy Colleges to Submit UGC Anti-Ragging Compliance Report by June 1 Farhat Nasim27 May 2025 7:38 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has issued a directive to all pharmacy institutions under its purview to strengthen their compliance...
CDSCO Panel Clears Abbott's Phase IV Trial for Empagliflozin + Metformin FDC, Seeks More Sites Dr. Divya Colin26 May 2025 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Abbott Healthcare...
Delhi HC Quashes IPO's Patent Rejection of Taiho Pharma's Cancer Drug, Orders Re-evaluation Farhat Nasim25 May 2025 4:00 PM ISTNew Delhi: In a ruling impacting pharmaceutical patent jurisprudence in India, the Delhi High Court has set aside the Indian Patent Office's (IPO)...
Macleods Gets CDSCO Panel Go Ahead For Semaglutide Trials, Preclinical Data Sought Farhat Nasim24 May 2025 9:54 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control Organisation...
Zydus Told to Withdraw Unmarketed Strengths, Conduct Phase IV Trial for Approved Combinations Only Dr. Divya Colin23 May 2025 9:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus Healthcare Ltd. to...
Drug alert: CDSCO flags 60 formulations as not of standard quality Ruchika Sharma22 May 2025 5:05 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has flagged sixty drug batches for failing to qualify for a random drug sample...
Eli Lilly Gets CDSCO Panel Nod To import, and market anticancer Selpercatinib Tablets Dr. Divya Colin21 May 2025 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz Farhat Nasim20 May 2025 8:24 PM ISTUS: In a stern regulatory move, the United States Food and Drug Administration (USFDA) has issued a warning letter to Virginia-based Sarfez...
D Pharma Student's Unlicensed Store Busted in Haryana, ACB Arrests Drug Official During Raid Farhat Nasim19 May 2025 6:35 PM ISTCharkhi Dadri: A final-year Diploma in Pharmacy (D. Pharma/D Pharm) student was caught running a medical store without a license in Morwala village....
DTAB Recommends Legal Provisions for OTC Drug Licensing Dr. Divya Colin18 May 2025 6:00 PM ISTNew Delhi: Considering the proposal for submission of report of the Sub-Committee constituted to examine the matter of Over-The-Counter (OTC) Drugs,...
Lindane to Stay in Market for Lice, Scabies Treatment, Says DTAB Farhat Nasim17 May 2025 8:37 PM ISTNew Delhi: Refusing to impose a complete ban, the Drugs Technical Advisory Board (DTAB) has recommended the continued marketing of Lindane, a topical...
